Atea Pharmaceuticals, Inc. — 10-Q Filings
16 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Atea Pharmaceuticals, Inc. (AVIR), sorted by most recent first. Each row links to the full filing on EdgarLookup. Atea Pharmaceuticals, Inc. has filed 16 10-Q documents with the SEC since 2013. To view all SEC filings by Atea Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DFAN14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-277815 | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-105123 | Aug 7, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0000950170-25-069367 | May 12, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0000950170-24-123447 | Nov 7, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-092914 | Aug 7, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0000950170-24-059699 | May 14, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0000950170-23-061213 | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-039920 | Aug 8, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0000950170-23-018869 | May 8, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0000950170-22-022699 | Nov 7, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-015570 | Aug 8, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0000950170-22-008732 | May 10, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001564590-21-056513 | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-044060 | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001564590-21-027644 | May 13, 2021 | Mar 31, 2021 |
| 10-Q | 10-Q | 0001564590-20-056724 | Dec 10, 2020 | Sep 30, 2020 |